Compare ESNT & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ESNT | TFX |
|---|---|---|
| Founded | 2008 | 1943 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.8B |
| IPO Year | 2013 | 1994 |
| Metric | ESNT | TFX |
|---|---|---|
| Price | $69.41 | $132.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | $67.29 | ★ $138.75 |
| AVG Volume (30 Days) | 481.3K | ★ 532.6K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.19% | 1.02% |
| EPS Growth | ★ 0.73 | N/A |
| EPS | ★ 3.89 | 2.08 |
| Revenue | $1,260,935,000.00 | ★ $1,992,713,000.00 |
| Revenue This Year | $1.12 | $15.97 |
| Revenue Next Year | $3.37 | $5.15 |
| P/E Ratio | ★ $17.85 | $63.98 |
| Revenue Growth | ★ 1.45 | N/A |
| 52 Week Low | $55.34 | $100.18 |
| 52 Week High | $70.00 | $145.00 |
| Indicator | ESNT | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 64.73 | 46.63 |
| Support Level | $63.90 | $129.02 |
| Resistance Level | $70.00 | $137.40 |
| Average True Range (ATR) | 1.63 | 5.00 |
| MACD | 0.13 | -0.48 |
| Stochastic Oscillator | 85.37 | 17.55 |
Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.